Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Eac Supply Disruption — GlaxoSmithKline LLC (Low Risk
Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Eac Supply Disruption — GlaxoSmithKline LLC (Low Risk is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Eac; Manufacturer: Glaxo
| Drug name | Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Eac |
|---|---|
| Manufacturer | GlaxoSmithKline LLC |
| Recall/Disruption reason | Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct ex |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0544-2024 |
| Initiation date | 20240517 |
| Quantity affected | 463 Cartons |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →